Telix Pharmaceuticals Limited Depreciation Expense
Telix Pharmaceuticals Limited (TLPPF) reported Depreciation Expense of $11.62 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2026-02-20
AUD
| Period end | Depreciation Expense 12 month |
|---|---|
| 2024-12-31 | 3.51M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 2.40M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 1.28M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Depreciation Expense 12 month |
|---|---|
| 2025-12-31 | $11.62M 20-F · filed 2026-02-20 |
| 2024-12-31 | $2.31M 20-F · filed 2026-02-20 |
| 2023-12-31 | $1.60M 20-F · filed 2026-02-20 |